Press Releases

Feb 25, 2021 9:20am EST

Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants

Feb 18, 2021 9:31am EST

CollPlant Issues Letter to Shareholders

Feb 18, 2021 7:00am EST

CollPlant Announces Closing of $35.0 Million Registered Direct Offering of American Depositary Shares

Feb 11, 2021 11:22pm EST

CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares

Feb 08, 2021 7:00am EST

CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products

Dec 10, 2020 7:00am EST

CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications

Dec 01, 2020 7:00am EST

CollPlant Biotechnologies Reports Third Quarter (Q3) 2020 Financial Results and Provides Business Update

Nov 10, 2020 7:00am EST

CollPlant Announces Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients

Oct 26, 2020 7:00am EDT

CollPlant Receives Substantial First Order for its Vergenix™ Flowable Gel Product in Ukraine

Sep 21, 2020 7:00am EDT

CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant